Carbon dots as inhibitors of virus by activation of type I interferon response

被引:113
|
作者
Du, Ting [1 ]
Liang, Jiangong [1 ]
Dong, Nan [2 ]
Liu, Lin [1 ]
Fang, Liurong [2 ]
Xiao, Shaobo [2 ]
Han, Heyou [1 ]
机构
[1] Huazhong Agr Univ, Coll Sci, Coll Food Sci & Technol, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China
[2] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China
基金
中国国家自然科学基金;
关键词
QUANTUM DOTS; PSEUDORABIES-VIRUS; ANTIVIRAL ACTIVITY; SILVER NANOPARTICLES; NANODOTS; INFECTION; PROTEIN; SURFACE; CHARGE; ENTRY;
D O I
10.1016/j.carbon.2016.09.032
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Carbon dots (CDs) has shown exciting potential in the field of bioscience and biotechnology due to their low toxicity, biological and ecological friendliness and desirable performance characteristics of quantum dots (QDs). However, the effects of CDs on viruses are still largely unknown. In this study, we investigate the effect of CDs on the replication of virus by using pseudorabies virus (PRV) and porcine reproductive and respiratory syndrome virus (PRRSV) as the models of DNA virus and RNA virus, respectively. Analyses of virus titers and the expression of viral proteins demonstrate that cells treated with CDs can significantly inhibit the multiplication of PRV and PRRSV. In mechanism, CDs treatment dramatically induces interferon-alpha (IFN-alpha) production and the expression of IFN-stimulating genes (ISGs) which in turn inhibits virus replication. Taken together, these results reveal a previously undefined role of CDs and provide a new strategy to develop antiviral agents. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:278 / 285
页数:8
相关论文
共 50 条
  • [1] Influenza A Virus TRIMs the Type I Interferon Response
    Ludwig, Stephan
    Wolff, Thorsten
    CELL HOST & MICROBE, 2009, 5 (05) : 420 - 421
  • [2] Dual Modulation of Type I Interferon Response by Bluetongue Virus
    Doceul, Virginie
    Chauveau, Emilie
    Lara, Estelle
    Breard, Emmanuel
    Sailleau, Corinne
    Zientara, Stephan
    Vitour, Damien
    JOURNAL OF VIROLOGY, 2014, 88 (18) : 10792 - 10802
  • [3] Activation of type I and III interferon response by mitochondrial and peroxisomal MAVS and inhibition by hepatitis C virus
    Bender, Silke
    Reuter, Antje
    Eberle, Florian
    Einhorn, Evelyne
    Binder, Marco
    Bartenschlager, Ralf
    CYTOKINE, 2015, 76 (01) : 85 - 85
  • [4] Activation of Type I and III Interferon Response by Mitochondrial and Peroxisomal MAVS and Inhibition by Hepatitis C Virus
    Bender, Silke
    Reuter, Antje
    Eberle, Florian
    Einhorn, Evelyne
    Binder, Marco
    Bartenschlager, Ralf
    PLOS PATHOGENS, 2015, 11 (11)
  • [5] Activation of the type I interferon response in rheumatoid arthritis: Role of interferon regulatory factors
    Sweeney, Susan E.
    Kimbler, Trevor B.
    Firestein, Gary S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S296 - S296
  • [6] Inhibition of Microprocessor Function during the Activation of the Type I Interferon Response
    Witteveldt, Jeroen
    Ivens, Alasdair
    Macias, Sara
    CELL REPORTS, 2018, 23 (11): : 3275 - 3285
  • [7] Activation of the Chicken Type I Interferon Response by Infectious Bronchitis Coronavirus
    Kint, Joeri
    Fernandez-Gutierrez, Marcela
    Maier, Helena J.
    Britton, Paul
    Langereis, Martijn A.
    Koumans, Joseph
    Wiegertjes, Geert F.
    Forlenza, Maria
    JOURNAL OF VIROLOGY, 2015, 89 (02) : 1156 - 1167
  • [8] Impact of Zika virus on the human type I interferon osteoimmune response
    Drouin, Arnaud
    Wallbillich, Nicholas
    Theberge, Marc
    Liu, Sharon
    Katz, Joshua
    Bellovoda, Kamela
    Cheon, Scarlett Se Yun
    Gootkind, Frederick
    Bierman, Emily
    Zavras, Jason
    Berberich, Matthew J.
    Kalocsay, Marian
    Guastaldi, Fernando
    Salvadori, Nicolas
    Troulis, Maria
    Fusco, Dahlene N.
    CYTOKINE, 2021, 137
  • [9] The C protein of measles virus inhibits the type I interferon response
    Shaffer, JA
    Bellini, WJ
    Rota, PA
    VIROLOGY, 2003, 315 (02) : 389 - 397
  • [10] Type I interferon activation in dermatomyositis
    Mlitzko, L.
    Fischer, K.
    Meisterfeld, S.
    Roesing, S.
    Drukewitz, S.
    Beissert, S.
    Guenther, C.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E70 - E71